Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumabl…
Medical - Devices
US, Menlo Park [HQ]
PACB/Financials
Wall Street · Earnings · Institutional Sentiment
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Pacific Biosciences of California, Inc.'s gradings, price targets and earnings estimates.
Earnings
See the historical earnings and what wall street
analysts forecasted and
forecast for
future earnings.
Reported
Past Estimate Consensus
Future Estimate Consensus
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2014 | -1.2600 | -1.020 | 28 | 65 | -79 | -68 | -71 | -61 | -77 | -65 | 38 | 40 |
| 2015 | -0.9400 | -0.425 | 60 | 92 | -66 | -28 | -59 | -20 | -62 | -25 | 38 | 53 |
| 2016 | -0.4200 | -0.851 | 92 | 88 | -31 | -79 | -51 | -71 | -52 | -75 | 45 | 50 |
| 2017 | -0.8300 | -0.897 | 90 | 90 | -74 | -90 | -67 | -79 | -71 | -87 | 47 | 57 |
| 2018 | -0.8700 | -0.680 | 93 | 80 | -92 | -76 | -89 | -69 | -89 | -75 | 59 | 47 |
| 2019 | -0.7600 | -0.717 | 78 | 88 | -102 | -66 | -100 | -53 | -100 | -97 | 63 | 76 |
| 2020 | -0.5100 | 0.173 | 90 | 76 | -77 | 16 | -99 | 25 | -100 | -130 | 75 | 72 |
| 2021 | 0.1800 | -0.854 | 78 | 130 | 29 | -177 | -102 | -239 | -104 | -197 | 72 | 117 |
| 2022 | -0.8900 | -1.385 | 130 | 127 | -181 | -191 | -178 | -255 | -178 | -276 | 124 | 121 |
| 2023 | -1.3200 | -1.177 | 128 | 199 | -296 | -306 | -297 | -291 | -304 | -314 | 160 | 160 |
| 2024 | - | -1.116 | - | 167 | - | -283 | - | -167 | - | -167 | - | 159 |
| 2025 | - | -0.688 | - | 211 | - | -199 | - | -211 | - | -211 | - | 201 |
| 2026 | - | -0.515 | - | 278 | - | 2.F12X | - | 2.F121 | - | 2.F1211 | - | 2.F1211 |
| 2027 | - | -0.393 | - | 346 | - | 1.F13X | - | 1.F131 | - | 1.F1311 | - | 1.F1311 |
| 2028 | - | -0.357 | - | 420 | - | 0.F14X | - | 0.F141 | - | 0.F1411 | - | 0.F1411 |
Institutional Sentiment
Wall Street · Earnings · Institutional Sentiment
Morgan Stanley
1Y Ago:
n/a
Prev. Grade
n/a
n/a
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
n/a
Overall Consensus
Grading Consensus
Price Target Consensus
-83.648% $1.33 · MISS
Nov. 6, 2024Price Then
$2.55
Price Target
$2.92
Price Now
$1.59